Edible Garden AG, a leader in controlled environment agriculture and sustainable produce, announced a conference call on November 16, 2026, to discuss its financial results for Q3 ending September 30, 2026, and provide a business update. The company operates advanced greenhouses and processing facilities across the US and is expanding its manufacturing hub for ready-to-drink nutrition products. This call will offer insights into its ongoing growth and innovation in organic produce and nutrition sectors. Investors can join via phone or webcast, with replays available on the company website.
Edible Garden's upcoming financial results call is context for US Consumer Staples market data. For readers following this sector, 41 of 63 stocks rose and 18 fell today. Notable movers include JBS at USD 12.10 with a 7.77% drop and 100% sell orders, 22nd Century Group at USD 1.52 down 6.75% with 77% buy orders, and Vita Coco at USD 65.57 up 1.67%. Data as of Nov 10, 2026 19:43 WIB.
project44 has partnered with Snowflake to enhance supply chain decision-making through Mo, an AI-powered supply chain analyst. Mo uses project44's extensive logistics data and Snowflake Cortex AI to provide accurate, consistent answers to complex sup...
H&R Block has launched the Emerald Advance Loan, a fixed-rate short-term loan up to $1,750 with a 35.90% APR, designed to help families cover year-end expenses without monthly payments. Borrowers repay the loan in full by March 31, 2027, with no impa...
Duke Robotics has entered a strategic collaboration with Greek security firm CRONOS to commercialize its Insulator Cleaning Drone (IC Drone) technology in Greece. This partnership leverages CRONOS's strong presence in Greece's critical infrastructure...
Alm. Brand A/S repurchased 1,369,397 shares between November 3 and 9, 2026, at an average price of DKK 17.46 per share. This is part of their announced buy-back program totaling up to DKK 593 million, aiming to reduce the number of outstanding shares...
Novartis has secured first place in the 2026 Access to Medicine Index, maintaining its lead since 2024 by excelling across all assessed technical areas, including governance, R&D, and product delivery. The company scored 3.86 out of 5 overall, with a...
